News

NatWest Group PLC, Pernod Ricard SA, Novo Nordisk A/S Class B, Software AG. Read 's Market Analysis on Investing.com UK.
Eli Lilly joins up with Camurus to make long-acting versions of the pharma's obesity and diabetes drugs, joining the industry ...